Theophylline inhibits the late asthmatic response to nighttime antigen challenge in patients with mild atopic asthma

Annals of Allergy, Asthma and Immunology

Volumn 81, Issue 3, 1998, Pages 231-236

  Jarjour, Nizar N ^a,c   Lacouture, Peter G ^b   Busse, William W ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b PURDUE PHARMA L P   (United States)

^c Section of Pulmonary and Critical Care Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; PLACEBO; SALBUTAMOL; THEOPHYLLINE;

ADULT; ALLERGIC ASTHMA; ARTICLE; CHRONOPHARMACOLOGY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; FORCED EXPIRATORY VOLUME; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; IMMUNOLOGICAL TOLERANCE; INHALATIONAL DRUG ADMINISTRATION; MALE; NEBULIZATION; NERVOUSNESS; NIGHT; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFLAMMATION; THEOPHYLLINE BLOOD LEVEL;

EID: 0031687942     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)62817-7     Document Type: Article

References (24)

1. Busse WW. Pathogenesis and pathophysiology of nocturnal asthma. Am J Med 1988;85:24S-29S.
2. Turner-Warwick M. Epidemiology of nocturnal asthma. Am J Med 1988;85: 6S-8S.
3. Lacouture PG, Comack I, Goldenheim PD, Martin RJ. ASK program: nocturnal asthma re-visited [Abstract]. Ann Allergy Asthma Immunol 1995;74: 89,P57.
4. Martin RJ, Cicutto LC, Smith HR, et al. Airways inflammation in nocturnal asthma. Am Rev Respir Dis 1991;143: 351-357.
5. O'Byrne PM, Dolovich J, Hargreave FE. Late asthmatic responses. Am Rev Respir Dis 1987;136:740-751.
6. Mohiuddin AA, Martin RJ. Circadian basis of the late asthmatic response. Am Rev Respir Dis 1990;142: 1153-1157.
7. Weinberger M, Hendeles L. Theophylline in asthma. N Engl J Med 1996; 334:1380-1388.
8. Crescioli S, Spinazzi A, Plebani M, et al. Theophylline inhibits immediate and late asthmatic reactions induced by allergens in asthmatic subjects. Ann Allergy 1991;66:245-251.
9. Pauwels R, Van Renterghem D, Van Der Straeten M, et al. The effect of theophylline and enprofylline on allergen-induced bronchoconstriction. J Allergy Clin Immunol 1985;76:583-590.
10. Hendeles L, Harman E, Huang D, et al. Theophylline attenuation during responses to allergen: comparison with cromolyn metered-dose inhaler. J Allergy Clin Immunol 1995;95:509-514.
11. Barnes PJ, Pauwels RA. Theophylline in the management of asthma: time for reappraisal? Eur Respir J 1994;7: 579-591.
12. Sullivan P, Bekir S, Jaffar Z, et al. Anti-inflammatory effects of low-dose oral theophylline in atopic asthma. Lancet 1994;343:1006-1008.
13. Kidney J, Dominguez M, Taylor PM, et al. Immunomodulation by theophylline in asthma. Demonstration by withdrawal of therapy. Am J Respir Crit Care Med 1995;151:1907-1914.
14. Kraft M, Torvik JA, Trudeau JB, et al. Theophylline: potential antiinflammatory effects in nocturnal asthma. J Allergy Clin Immunol 1996;97: 1242-1246.
15. Kraft M, Pak J, Borish L, Martin RJ. Theophylline's effect on neutrophil function and the late asthmatic response. J Allergy Clin Immunol 1996; 98:251-257.
16. Fanta CH, McFadden ER Jr. Pharmacokinetics and clinical response to single- and multiple-dose sustained-release theophylline compounds in perennial bronchial asthma. Am J Med 1985;79:54S-57S.
17. DuBuske LM. Asthma: diagnosis and management of nocturnal symptoms. Compr Ther 1994;20:628-639.
18. Medical Section of the American Lung Association. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987;136:225-244.
19. Chai H, Farr R, Froelich LA. Standardization of inhalation challenge procedures. J Allergy Clin Immunol 1975; 56:323-327.
20. Arkinstall WW, Atkins ME, Harrison D, Stewart JH. Once-daily sustained-release theophylline reduces diurnal variation in spirometry and symptomatology in adult asthmatics. Am Rev Respir Dis 1987;135:315-321.
21. Rivington RN, Calcutt L, Child S, et al. Comparison of morning versus evening dosing with a new once-daily oral theophylline formulation. Am J Med 1985;79:67-72.
22. Lai CK, Twentyman OP, Holgate ST. The effect of an increase in inhaled allergen dose after rimiterol hydrobromide on the occurrence and magnitude of the late asthmatic response and associated change in nonspecific bronchial responsiveness. Am Rev Respir Dis 1989;140:917-923.
23. De Monchy JGR, Kauffman HF, Venge P, et al. Bronchoalveolar eosinophilia during allergen-induced late asthmatic reaction. Am Rev Respir Dis 1985;131:373-376.
24. Silvestri M, Oddera S, Sacco O, et al. Bronchoalveolar lavage inflammation in single early and dual responders after allergen inhalation challenge. Lung 1997;175:277-285.